On heels of Bain buyout, Tanabe inks deal to sell manufacturing unit and 17 drugs to Towa

Following a major push by the industry’s heavyweights to simplify their businesses in recent years, Tanabe Pharma is | While not on the same scale of some of Big Pharma’s major carveouts in recent years, the deal follows a noticeable pattern in which diversified drugmakers have simplified their structures to focus more on innovative medicines.